This Week in Psychedelics - 2.11.22

Cannabis

• South Carolina Medical Marijuana Legalization Bill Officially Approved In Senate, Heads For House Consideration (Marijuana Moment)

• Maryland Lawmakers Introduce Adult-Use Cannabis Legalization Bill (High Times)

• UK trial of medical cannabis and long covid to get underway this month (Cannabis Health News)

• The Super Bowl won’t be lit: no cannabis ads allowed (The Verge)

• Bill Introduced to Raise THC Limit in Hemp to One Percent (High Times)

• Cannabis Store Co-owned By Top Virginia Senator Sells Mislabeled Products With Illegal THC Content, Media Investigation Finds (Marijuana Moment)

• Study Shreds Cannabis ‘Amotivational Syndrome’ Theory (High Times)

• Flower still king of US marijuana market, though supremacy waning (Marijuana Business Daily)

• Oklahoma Becomes Marijuana Legalization Battleground Between Advocates, With Legal Challenges And A New Ballot Initiative (Marijuana Moment)

• New York Cracks Down on Illegal Cannabis Businesses (High Times)

• Missouri Supreme Court Unanimously Orders Medical Marijuana Applicant Disclosures (Marijuana Moment)

• Pennsylvania Senate committee holds first-ever hearing on legalizing recreational marijuana (WGAL)

• Police Seizure Of Marijuana Dispensary Cash Leads To Federal Litigation (Marijuana Moment)

• Cannabis platform Leafly closes merger with SPAC, goes public on Nasdaq (Marijuana Business Daily)

• The Eternal Pricing Struggle of UK Medical Cannabis Patients (TalkingDrugs)

• Weedmaps Ad Satirizes Plight Of Broccoli Emoji As Marijuana Stand-In On Social Media (Marijuana Moment)

• Young cannabis users at increased risk of repeat stroke (Medical News Today)

• Federally Owned Utility Company Walks Back Threat To Block Electricity For Marijuana Businesses (Marijuana Moment)

• Cali Vibes Rocks Long Beach, Allowing Cannabis (High Times)

• How does cannabis use affect brain health? Caution advised, more research needed, experts say (ScienceDaily)

LSD

• Microdose Psychedelics Presents a Molecular Masterclass: The LSD Conference (GlobeNewswire)

Magic Mushrooms

• Psilocybin microdosing does not reduce symptoms of depression or anxiety, according to placebo-controlled study (PsyPost)

• Lawmakers say no to bill legalizing psilocybin-assisted therapy in Maine (The Portland Press Herald)

• Oregon proposes only using one type of mushroom for new psilocybin system, and no pills (OPB)

• More States Follow Oregon’s Lead Toward Legal Psilocybin Therapy (Lucid News)

• Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs (Business Wire)

• Maine CDC Director Opposes Bill to Legalize Therapeutic Psilocybin (Psychedelic Spotlight)

• The Many Types of Psychedelic Mushrooms (Truffle Report)

• Mazatec Shamanic Knowledge and Psilocybin Mushrooms (Chacruna)

MDMA

• Can MDMA Save a Marriage? (The New York Times)

DMT

• DMT Vape Pen Patent Illustrates a Big Problem in the Psychedelics Industry (Psychedelic Spotlight)

Ayahuasca

• Creating Awareness on Sexual Abuse in Ayahuasca Communities: A Review of Chacruna’s Guidelines (Chacruna)

5-MeO-DMT

• Scientists Create Cell-Based Psychedelic Toad Venom, a Potential 5-MeO-DMT “Bio-Factory” (Lucid News)

Mescaline

• Mescaline As Therapy Is Getting Attention, Despite Stigma (Green Market Report)

Iboga

• Osoyoos Indian Band eyes cutting-edge drug treatment centre (Vancouver Sun)

Novel Psychoactive Substances

• Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

Nitrous Oxide

• Another new weapon to beat Corona, first 'nasal spray' launched in India (News Track)

• Nitrous Oxide Safe For Dental Procedures In Children With Sickle Cell Disease: Study (Medical Dialogues)

Ketamine

• Ketamine effectively silences suicidal thoughts, especially in bipolar patients (Study Finds)

• Researching Ketamine for Social Anxiety Disorder (Truffle Report)

• Yale researcher receives grant to study effects of ketamine in individuals with epilepsy (Yale Daily News)

• Trip Tunes: A Conversation with Producer Jon Hopkins About Making Music for Ketamine (DoubleBlind)

• Ketamine Infusions in the Home May Facilitate Safe Treatment Access During the Pandemic (Pharmacy Times)

Miscellaneous

• Can microdosing psychedelics boost mental health? Here’s what the evidence suggests. (National Geographic)

• Utah House Overwhelmingly Approves Psychedelics Study Task Force Bill (Marijuana Moment)

• Maryland Senate Bill Would Provide ‘Cost-Free Access’ To Psychedelics For Military Veterans (Marijuana Moment)

• Psychedelics Offer New Route to Recovery from Eating Disorders (NEO.LIFE)

• Are Psychedelics the Future of Pain Relief? (VICE)

• Michigan Activists Submit Psychedelics Decriminalization Language (High Times)

• DEA Faces Backlash Over Proposed Scheduling Of Five Psychedelic Compounds (Marijuana Moment)

• Proposed Drug-Decrim Ballot Initiative All Set in Washington State (Filter)

• Can Psychedelics Make People More Drawn to Conspiracy Theories? (Sam Woolfe)

• Yes, Psychedelics Do Change Our Metaphysical Beliefs (DoubleBlind)

• Panel Discusses Coalition Building to Unlock Therapeutic Effects of Psychedelics (The Yale School)

• Legal Psychedelics: The U.S. Cities Where Psilocybin, LSD And Others Are Decriminalized (Healing Maps)

• Canada’s Reforms on Psychedelics Are Slowly Taking Shape (Bloomberg)

• Survey Shows 65% of Affected Americans Want Access to Psychedelic Treatments for Mental Health Conditions (Pharmacy Times)

• New Polling by Mind Medicine Australia Reveals Over 60% of Australians Support Increased Access to Psychedelic Medicines (Mind Medicine Australia)

• Big Pharma In Psychedelics: Inside Mindset Pharma’s Deal With Otsuka (Forbes)

• Using Real-World Evidence to Accelerate Psychedelic Drug Development (Truffle Report)

• Is city getting ‘high’ on hallucinating drugs? (The Hindu)

• Drug Euphoria Is a Good Thing, Actually (Filter)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.